RSS Worldwide Bio News

  • I Am Grateful for Everything — Even MS
    This post was originally published on this site Last week, CNN’s Anderson Cooper broadcast an interview with “The Late Show” host Stephen Colbert. They had a lively discussion about comedy, politics, careers, and the like, but perhaps the most stunning eight minutes of the interview were focused on grief. Colbert, a devout Catholic, said, “It’s […]
  • Finding the Motivation to Avoid the ‘Caregiving Slump’
    This post was originally published on this site Life doesn’t come to a screeching halt while you care for a person who has Alzheimer’s disease. Time marches on for familial caregivers. There is a certain fluidity to life. We want to go with the flow, but it is difficult as we swim against the current. […]
  • Life Is Better with a Local MS Nurse
    This post was originally published on this site I was struck down by sclerosis in 2006 — literally. I was playing tennis and ran to return a drop shot. I never made it, but I did drop myself and rupture my right shoulder. It was so severe that it took two operations to rectify. The […]
  • Cognitive and Psychiatric Issues Linked to Autoantibodies in Brain Unique to Lupus Patients, Study Finds
    This post was originally published on this site Autoantibodies targeting certain regulatory RNAs — molecules that serve as the template for protein production — in the brains of lupus patients are unique to these people and involved in neuropsychiatric symptoms of the disease, a study reports. The study, “Neuronal BC RNA transport impairments caused by systemic lupus erythematosus autoantibodies,” […]
  • 31 Days of SMA: When Two Siblings Have SMA
    This post was originally published on this site View this post on Instagram Day 23 of 31 Days of SMA⁣⠀ Topic: Siblings with SMA⁣⠀ ⁣⠀ This is Natalie’s story! ⁣⠀ In order for someone to have SMA, both parents must be carriers of the gene. If both parents are in fact carriers, there is a […]
  • Lynparza-Avastin Combo Cuts Risk of Disease Progression, Death in Advanced OC, Phase 3 Trial Shows
    This post was originally published on this site When added to Avastin (bevacizumab), Lynparza (olaparib) reduces the risk of disease progression and death in women with advanced forms of ovarian cancer who are responding to their first-line treatment with platinum-based chemotherapy, a Phase 3 trial shows. Lynparza is an oral anti-cancer treatment jointly developed by AstraZeneca and Merck […]
  • Kalytera’s Cannabidiol Prevents Graft-Versus-Host-Disease After Bone Marrow Transplant, Data Show
    This post was originally published on this site Kalytera’s cannabidiol (CBD) compound efficiently prevents graft-versus-host disease (GVHD) in patients receiving bone marrow transplants from matched unrelated donors, interim data from a Phase 2 study show. Considering the study’s positive results so far, the company announced that it will halt the Phase 2 study and proceed directly […]
  • NKTR-214 with Opdivo Earns FDA’s Breakthrough Therapy Designation for Advanced Melanoma
    This post was originally published on this site The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for a combination of the potential therapy NKTR-214 with Opdivo (nivolumab) for untreated melanoma patients with either metastatic disease or who are unable to undergo surgery. A global Phase 3 clinical trial (NCT03635983) comparing the effectiveness and safety […]
  • FDA Grants Priority Review to Zanubrutinib as Treatment for Mantle Cell Lymphoma
    This post was originally published on this site The U.S. Food and Drug Administration (FDA) has accepted for review BeiGene‘s application requesting the approval of zanubrutinib for treating people with mantle cell lymphoma who received at least one prior therapy. BeiGene’s new drug application (NDA) received priority review status, which reduces review time from the […]
  • This ‘Advocacy August,’ Let’s Educate Our Elected Officials About PH
    This post was originally published on this site “Advocacy August” is here. Because pulmonary hypertension (PH) is a rare disease and has no cure, it is necessary that we promote awareness among those who can make a difference in our lives. When it comes to government decisions, advocacy means helping people who might otherwise be […]